Osteoporosis Therapeutics market worldwide is projected to grow by US$3. 7 Billion, driven by a compounded growth of 3. 8%. Bisphosphonates, one of the segments analyzed and sized in this study, displays the potential to grow at over 4.

New York, Oct. 18, 2019 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Osteoporosis Therapeutics Industry" - https://www.reportlinker.com/p05817617/?utm_source=GNW
4%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$6.7 Billion by the year 2025, Bisphosphonates will bring in healthy gains adding significant momentum to global growth.

- Representing the developed world, the United States will maintain a 3% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$133.8 Million to the region’s size and clout in the next 5 to 6 years. Over US$107.4 Million worth of projected demand in the region will come from Rest of Europe markets. In Japan, Bisphosphonates will reach a market size of US$371.4 Million by the close of the analysis period. As the world’s second largest economy and the new game changer in global markets, China exhibits the potential to grow at 6% over the next couple of years and add approximately US$1 Billion in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders. Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific, Latin America and the Middle East. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

- Competitors identified in this market include among others, Allergan PLC; Allergan PLC; Amgen, Inc.; Eli Lilly and Company; F. Hoffmann-La Roche AG; GlaxoSmithKline PLC; Merck KGaA; Novartis International AG; Novo Nordisk A/S; Pfizer, Inc.; Teva Pharmaceutical Industries Ltd.


Read the full report: https://www.reportlinker.com/p05817617/?utm_source=GNW

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Global Competitor Market Shares
Osteoporosis Therapeutics Competitor Market Share Scenario
Worldwide (in %): 2019 & 2028
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
Table 1: Osteoporosis Therapeutics Global Market Estimates and
Forecasts in US$ Million by Region/Country: 2018-2025
Table 2: Osteoporosis Therapeutics Global Retrospective Market
Scenario in US$ Million by Region/Country: 2009-2017
Table 3: Osteoporosis Therapeutics Market Share Shift across
Key Geographies Worldwide: 2009 VS 2019 VS 2025
Table 4: Bisphosphonates (Drug Type) World Market by
Region/Country in US$ Million: 2018 to 2025
Table 5: Bisphosphonates (Drug Type) Historic Market Analysis
by Region/Country in US$ Million: 2009 to 2017
Table 6: Bisphosphonates (Drug Type) Market Share Breakdown of
Worldwide Sales by Region/Country: 2009 VS 2019 VS 2025
Table 7: Parathyroid Hormone Therapy (Drug Type) Potential
Growth Markets Worldwide in US$ Million: 2018 to 2025
Table 8: Parathyroid Hormone Therapy (Drug Type) Historic
Market Perspective by Region/Country in US$ Million: 2009 to
2017
Table 9: Parathyroid Hormone Therapy (Drug Type) Market Sales
Breakdown by Region/Country in Percentage: 2009 VS 2019 VS 2025
Table 10: Calcitonin (Drug Type) Geographic Market Spread
Worldwide in US$ Million: 2018 to 2025
Table 11: Calcitonin (Drug Type) Region Wise Breakdown of
Global Historic Demand in US$ Million: 2009 to 2017
Table 12: Calcitonin (Drug Type) Market Share Distribution in
Percentage by Region/Country: 2009 VS 2019 VS 2025
Table 13: Selective Estrogen Inhibitors Modulator (SERM) (Drug
Type) World Market Estimates and Forecasts by Region/Country in
US$ Million: 2018 to 2025
Table 14: Selective Estrogen Inhibitors Modulator (SERM) (Drug
Type) Market Historic Review by Region/Country in US$ Million:
2009 to 2017
Table 15: Selective Estrogen Inhibitors Modulator (SERM) (Drug
Type) Market Share Breakdown by Region/Country: 2009 VS 2019 VS
2025
Table 16: Rank Ligand Inhibitors (Drug Type) World Market by
Region/Country in US$ Million: 2018 to 2025
Table 17: Rank Ligand Inhibitors (Drug Type) Historic Market
Analysis by Region/Country in US$ Million: 2009 to 2017
Table 18: Rank Ligand Inhibitors (Drug Type) Market Share
Distribution in Percentage by Region/Country: 2009 VS 2019 VS
2025

III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS
UNITED STATES
Market Facts & Figures
US Osteoporosis Therapeutics Market Share (in %) by Company:
2019 & 2025
Table 19: United States Osteoporosis Therapeutics Market
Estimates and Projections in US$ Million by Drug Type: 2018 to
2025
Table 20: Osteoporosis Therapeutics Market in the United States
by Drug Type: A Historic Review in US$ Million for 2009-2017
Table 21: United States Osteoporosis Therapeutics Market Share
Breakdown by Drug Type: 2009 VS 2019 VS 2025
CANADA
Table 22: Canadian Osteoporosis Therapeutics Market Estimates
and Forecasts in US$ Million by Drug Type: 2018 to 2025
Table 23: Canadian Osteoporosis Therapeutics Historic Market
Review by Drug Type in US$ Million: 2009-2017
Table 24: Osteoporosis Therapeutics Market in Canada:
Percentage Share Breakdown of Sales by Drug Type for 2009,
2019, and 2025
JAPAN
Table 25: Japanese Market for Osteoporosis Therapeutics: Annual
Sales Estimates and Projections in US$ Million by Drug Type for
the Period 2018-2025
Table 26: Osteoporosis Therapeutics Market in Japan: Historic
Sales Analysis in US$ Million by Drug Type for the Period
2009-2017
Table 27: Japanese Osteoporosis Therapeutics Market Share
Analysis by Drug Type: 2009 VS 2019 VS 2025
CHINA
Table 28: Chinese Osteoporosis Therapeutics Market Growth
Prospects in US$ Million by Drug Type for the Period 2018-2025
Table 29: Osteoporosis Therapeutics Historic Market Analysis in
China in US$ Million by Drug Type: 2009-2017
Table 30: Chinese Osteoporosis Therapeutics Market by Drug
Type: Percentage Breakdown of Sales for 2009, 2019, and 2025
EUROPE
Market Facts & Figures
European Osteoporosis Therapeutics Market: Competitor Market
Share Scenario (in %) for 2019 & 2025
Table 31: European Osteoporosis Therapeutics Market Demand
Scenario in US$ Million by Region/Country: 2018-2025
Table 32: Osteoporosis Therapeutics Market in Europe: A
Historic Market Perspective in US$ Million by Region/Country
for the Period 2009-2017
Table 33: European Osteoporosis Therapeutics Market Share Shift
by Region/Country: 2009 VS 2019 VS 2025
Table 34: European Osteoporosis Therapeutics Market Estimates
and Forecasts in US$ Million by Drug Type: 2018-2025
Table 35: Osteoporosis Therapeutics Market in Europe in US$
Million by Drug Type: A Historic Review for the Period
2009-2017
Table 36: European Osteoporosis Therapeutics Market Share
Breakdown by Drug Type: 2009 VS 2019 VS 2025
FRANCE
Table 37: Osteoporosis Therapeutics Market in France by Drug
Type: Estimates and Projections in US$ Million for the Period
2018-2025
Table 38: French Osteoporosis Therapeutics Historic Market
Scenario in US$ Million by Drug Type: 2009-2017
Table 39: French Osteoporosis Therapeutics Market Share
Analysis by Drug Type: 2009 VS 2019 VS 2025
GERMANY
Table 40: Osteoporosis Therapeutics Market in Germany: Recent
Past, Current and Future Analysis in US$ Million by Drug Type
for the Period 2018-2025
Table 41: German Osteoporosis Therapeutics Historic Market
Analysis in US$ Million by Drug Type: 2009-2017
Table 42: German Osteoporosis Therapeutics Market Share
Breakdown by Drug Type: 2009 VS 2019 VS 2025
ITALY
Table 43: Italian Osteoporosis Therapeutics Market Growth
Prospects in US$ Million by Drug Type for the Period 2018-2025
Table 44: Osteoporosis Therapeutics Historic Market Analysis in
Italy in US$ Million by Drug Type: 2009-2017
Table 45: Italian Osteoporosis Therapeutics Market by Drug
Type: Percentage Breakdown of Sales for 2009, 2019, and 2025
UNITED KINGDOM
Table 46: United Kingdom Market for Osteoporosis Therapeutics:
Annual Sales Estimates and Projections in US$ Million by Drug
Type for the Period 2018-2025
Table 47: Osteoporosis Therapeutics Market in the United
Kingdom: Historic Sales Analysis in US$ Million by Drug Type
for the Period 2009-2017
Table 48: United Kingdom Osteoporosis Therapeutics Market Share
Analysis by Drug Type: 2009 VS 2019 VS 2025
SPAIN
Table 49: Spanish Osteoporosis Therapeutics Market Estimates
and Forecasts in US$ Million by Drug Type: 2018 to 2025
Table 50: Spanish Osteoporosis Therapeutics Historic Market
Review by Drug Type in US$ Million: 2009-2017
Table 51: Osteoporosis Therapeutics Market in Spain: Percentage
Share Breakdown of Sales by Drug Type for 2009, 2019, and 2025
RUSSIA
Table 52: Russian Osteoporosis Therapeutics Market Estimates
and Projections in US$ Million by Drug Type: 2018 to 2025
Table 53: Osteoporosis Therapeutics Market in Russia by Drug
Type: A Historic Review in US$ Million for 2009-2017
Table 54: Russian Osteoporosis Therapeutics Market Share
Breakdown by Drug Type: 2009 VS 2019 VS 2025
REST OF EUROPE
Table 55: Rest of Europe Osteoporosis Therapeutics Market
Estimates and Forecasts in US$ Million by Drug Type: 2018-2025
Table 56: Osteoporosis Therapeutics Market in Rest of Europe in
US$ Million by Drug Type: A Historic Review for the Period
2009-2017
Table 57: Rest of Europe Osteoporosis Therapeutics Market Share
Breakdown by Drug Type: 2009 VS 2019 VS 2025
ASIA-PACIFIC
Table 58: Asia-Pacific Osteoporosis Therapeutics Market
Estimates and Forecasts in US$ Million by Region/Country:
2018-2025
Table 59: Osteoporosis Therapeutics Market in Asia-Pacific:
Historic Market Analysis in US$ Million by Region/Country for
the Period 2009-2017
Table 60: Asia-Pacific Osteoporosis Therapeutics Market Share
Analysis by Region/Country: 2009 VS 2019 VS 2025
Table 61: Osteoporosis Therapeutics Market in Asia-Pacific by
Drug Type: Estimates and Projections in US$ Million for the
Period 2018-2025
Table 62: Asia-Pacific Osteoporosis Therapeutics Historic
Market Scenario in US$ Million by Drug Type: 2009-2017
Table 63: Asia-Pacific Osteoporosis Therapeutics Market Share
Analysis by Drug Type: 2009 VS 2019 VS 2025
AUSTRALIA
Table 64: Osteoporosis Therapeutics Market in Australia: Recent
Past, Current and Future Analysis in US$ Million by Drug Type
for the Period 2018-2025
Table 65: Australian Osteoporosis Therapeutics Historic Market
Analysis in US$ Million by Drug Type: 2009-2017
Table 66: Australian Osteoporosis Therapeutics Market Share
Breakdown by Drug Type: 2009 VS 2019 VS 2025
INDIA
Table 67: Indian Osteoporosis Therapeutics Market Estimates and
Forecasts in US$ Million by Drug Type: 2018 to 2025
Table 68: Indian Osteoporosis Therapeutics Historic Market
Review by Drug Type in US$ Million: 2009-2017
Table 69: Osteoporosis Therapeutics Market in India: Percentage
Share Breakdown of Sales by Drug Type for 2009, 2019, and 2025
SOUTH KOREA
Table 70: Osteoporosis Therapeutics Market in South Korea:
Recent Past, Current and Future Analysis in US$ Million by Drug
Type for the Period 2018-2025
Table 71: South Korean Osteoporosis Therapeutics Historic
Market Analysis in US$ Million by Drug Type: 2009-2017
Table 72: Osteoporosis Therapeutics Market Share Distribution
in South Korea by Drug Type: 2009 VS 2019 VS 2025
REST OF ASIA-PACIFIC
Table 73: Rest of Asia-Pacific Market for Osteoporosis
Therapeutics: Annual Sales Estimates and Projections in US$
Million by Drug Type for the Period 2018-2025
Table 74: Osteoporosis Therapeutics Market in Rest of
Asia-Pacific: Historic Sales Analysis in US$ Million by Drug
Type for the Period 2009-2017
Table 75: Rest of Asia-Pacific Osteoporosis Therapeutics Market
Share Analysis by Drug Type: 2009 VS 2019 VS 2025
LATIN AMERICA
Table 76: Latin American Osteoporosis Therapeutics Market
Trends by Region/Country in US$ Million: 2018-2025
Table 77: Osteoporosis Therapeutics Market in Latin America in
US$ Million by Region/Country: A Historic Perspective for the
Period 2009-2017
Table 78: Latin American Osteoporosis Therapeutics Market
Percentage Breakdown of Sales by Region/Country: 2009, 2019,
and 2025
Table 79: Latin American Osteoporosis Therapeutics Market
Growth Prospects in US$ Million by Drug Type for the Period
2018-2025
Table 80: Osteoporosis Therapeutics Historic Market Analysis in
Latin America in US$ Million by Drug Type: 2009-2017
Table 81: Latin American Osteoporosis Therapeutics Market by
Drug Type: Percentage Breakdown of Sales for 2009, 2019, and
2025
ARGENTINA
Table 82: Argentinean Osteoporosis Therapeutics Market
Estimates and Forecasts in US$ Million by Drug Type: 2018-2025
Table 83: Osteoporosis Therapeutics Market in Argentina in US$
Million by Drug Type: A Historic Review for the Period
2009-2017
Table 84: Argentinean Osteoporosis Therapeutics Market Share
Breakdown by Drug Type: 2009 VS 2019 VS 2025
BRAZIL
Table 85: Osteoporosis Therapeutics Market in Brazil by Drug
Type: Estimates and Projections in US$ Million for the Period
2018-2025
Table 86: Brazilian Osteoporosis Therapeutics Historic Market
Scenario in US$ Million by Drug Type: 2009-2017
Table 87: Brazilian Osteoporosis Therapeutics Market Share
Analysis by Drug Type: 2009 VS 2019 VS 2025
MEXICO
Table 88: Osteoporosis Therapeutics Market in Mexico: Recent
Past, Current and Future Analysis in US$ Million by Drug Type
for the Period 2018-2025
Table 89: Mexican Osteoporosis Therapeutics Historic Market
Analysis in US$ Million by Drug Type: 2009-2017
Table 90: Mexican Osteoporosis Therapeutics Market Share
Breakdown by Drug Type: 2009 VS 2019 VS 2025
REST OF LATIN AMERICA
Table 91: Rest of Latin America Osteoporosis Therapeutics
Market Estimates and Projections in US$ Million by Drug Type:
2018 to 2025
Table 92: Osteoporosis Therapeutics Market in Rest of Latin
America by Drug Type: A Historic Review in US$ Million for
2009-2017
Table 93: Rest of Latin America Osteoporosis Therapeutics
Market Share Breakdown by Drug Type: 2009 VS 2019 VS 2025
MIDDLE EAST
Table 94: The Middle East Osteoporosis Therapeutics Market
Estimates and Forecasts in US$ Million by Region/Country:
2018-2025
Table 95: Osteoporosis Therapeutics Market in the Middle East
by Region/Country in US$ Million: 2009-2017
Table 96: The Middle East Osteoporosis Therapeutics Market
Share Breakdown by Region/Country: 2009, 2019, and 2025
Table 97: The Middle East Osteoporosis Therapeutics Market
Estimates and Forecasts in US$ Million by Drug Type: 2018 to
2025
Table 98: The Middle East Osteoporosis Therapeutics Historic
Market by Drug Type in US$ Million: 2009-2017
Table 99: Osteoporosis Therapeutics Market in the Middle East:
Percentage Share Breakdown of Sales by Drug Type for 2009,
2019, and 2025
IRAN
Table 100: Iranian Market for Osteoporosis Therapeutics: Annual
Sales Estimates and Projections in US$ Million by Drug Type for
the Period 2018-2025
Table 101: Osteoporosis Therapeutics Market in Iran: Historic
Sales Analysis in US$ Million by Drug Type for the Period
2009-2017
Table 102: Iranian Osteoporosis Therapeutics Market Share
Analysis by Drug Type: 2009 VS 2019 VS 2025
ISRAEL
Table 103: Israeli Osteoporosis Therapeutics Market Estimates
and Forecasts in US$ Million by Drug Type: 2018-2025
Table 104: Osteoporosis Therapeutics Market in Israel in US$
Million by Drug Type: A Historic Review for the Period
2009-2017
Table 105: Israeli Osteoporosis Therapeutics Market Share
Breakdown by Drug Type: 2009 VS 2019 VS 2025
SAUDI ARABIA
Table 106: Saudi Arabian Osteoporosis Therapeutics Market
Growth Prospects in US$ Million by Drug Type for the Period
2018-2025
Table 107: Osteoporosis Therapeutics Historic Market Analysis
in Saudi Arabia in US$ Million by Drug Type: 2009-2017
Table 108: Saudi Arabian Osteoporosis Therapeutics Market by
Drug Type: Percentage Breakdown of Sales for 2009, 2019, and
2025
UNITED ARAB EMIRATES
Table 109: Osteoporosis Therapeutics Market in the United Arab
Emirates: Recent Past, Current and Future Analysis in US$
Million by Drug Type for the Period 2018-2025
Table 110: United Arab Emirates Osteoporosis Therapeutics
Historic Market Analysis in US$ Million by Drug Type: 2009-2017
Table 111: Osteoporosis Therapeutics Market Share Distribution
in United Arab Emirates by Drug Type: 2009 VS 2019 VS 2025
REST OF MIDDLE EAST
Table 112: Osteoporosis Therapeutics Market in Rest of Middle
East: Recent Past, Current and Future Analysis in US$ Million
by Drug Type for the Period 2018-2025
Table 113: Rest of Middle East Osteoporosis Therapeutics
Historic Market Analysis in US$ Million by Drug Type: 2009-2017
Table 114: Rest of Middle East Osteoporosis Therapeutics Market
Share Breakdown by Drug Type: 2009 VS 2019 VS 2025
AFRICA
Table 115: African Osteoporosis Therapeutics Market Estimates
and Projections in US$ Million by Drug Type: 2018 to 2025
Table 116: Osteoporosis Therapeutics Market in Africa by Drug
Type: A Historic Review in US$ Million for 2009-2017
Table 117: African Osteoporosis Therapeutics Market Share
Breakdown by Drug Type: 2009 VS 2019 VS 2025

IV. COMPETITION

ALLERGAN PLC
AMGEN
ELI LILLY AND COMPANY
F. HOFFMANN-LA ROCHE AG
GLAXOSMITHKLINE PLC
MERCK KGAA
NOVARTIS INTERNATIONAL AG
NOVO NORDISK A/S
PFIZER
TEVA PHARMACEUTICAL INDUSTRIES

V. CURATED RESEARCH
Read the full report: https://www.reportlinker.com/p05817617/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.